Localized ultrasound enhances delivery of rapamycin from microbubbles to prevent smooth muscle proliferation.
暂无分享,去创建一个
[1] D. Mozaffarian,et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.
[2] G. Unger,et al. Tacrolimus-eluting carbon-coated stents versus sirolimus-eluting stents for prevention of symptom-driven clinical end points , 2010, Clinical Research in Cardiology.
[3] Richard Manasseh,et al. Cavitation microstreaming and stress fields created by microbubbles. , 2010, Ultrasonics.
[4] Zhigang Wang,et al. Antitumor Effect of Docetaxel‐Loaded Lipid Microbubbles Combined With Ultrasound‐Targeted Microbubble Activation on VX2 Rabbit Liver Tumors , 2010, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[5] K. Ley,et al. Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[6] J. Hossack,et al. Focused in vivo Delivery of Plasmid DNA to the Porcine Vascular Wall via Intravascular Ultrasound Destruction of Microbubbles , 2009, Journal of Vascular Research.
[7] J. Hossack,et al. Intravascular ultrasound detection and delivery of molecularly targeted microbubbles for gene delivery , 2009, 2009 IEEE International Ultrasonics Symposium.
[8] Raffi Karshafian,et al. Sonoporation by ultrasound-activated microbubble contrast agents: effect of acoustic exposure parameters on cell membrane permeability and cell viability. , 2009, Ultrasound in medicine & biology.
[9] Nico de Jong,et al. Ultrasound and Microbubble-Targeted Delivery of Macromolecules Is Regulated by Induction of Endocytosis and Pore Formation , 2009, Circulation research.
[10] A. Kastrati,et al. Drug-Eluting Stents in Percutaneous Coronary Intervention , 2009, Drug safety.
[11] Shelton D Caruthers,et al. Intramural Delivery of Rapamycin With &agr;v&bgr;3-Targeted Paramagnetic Nanoparticles Inhibits Stenosis After Balloon Injury , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[12] William Wijns,et al. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. , 2007, Circulation.
[13] Mark Borden,et al. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. , 2007, Annual review of biomedical engineering.
[14] David B Matchar,et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. , 2007, JAMA.
[15] Katherine W Ferrara,et al. Therapeutic effects of paclitaxel-containing ultrasound contrast agents. , 2006, Ultrasound in medicine & biology.
[16] Jeffrey C Bamber,et al. Physical parameters affecting ultrasound/microbubble-mediated gene delivery efficiency in vitro. , 2006, Ultrasound in medicine & biology.
[17] Nico de Jong,et al. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[18] Adnan Kastrati,et al. Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different. , 2006, Journal of the American College of Cardiology.
[19] Yan Ling Zhang,et al. Development and Validation of a High-Throughput Assay for Quantification of the Proliferation Inhibitor ABT-578 Using LC/LC-MS/MS in Blood and Tissue Samples , 2005, Therapeutic drug monitoring.
[20] R. Falotico,et al. Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries. , 2005, European journal of pharmacology.
[21] Yun Zhou,et al. Study of sonoporation dynamics affected by ultrasound duty cycle. , 2005, Ultrasound in medicine & biology.
[22] Antonio Colombo,et al. Novel site‐specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[23] Raffi Bekeredjian,et al. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. , 2005, Journal of the American College of Cardiology.
[24] Nico de Jong,et al. Ultrasound-induced encapsulated microbubble phenomena. , 2004, Ultrasound in medicine & biology.
[25] E. Unger,et al. Therapeutic applications of lipid-coated microbubbles. , 2004, Advanced drug delivery reviews.
[26] Cheri X Deng,et al. Ultrasound-induced cell membrane porosity. , 2004, Ultrasound in medicine & biology.
[27] Sanjiv Kaul,et al. Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. , 2003, Ultrasound in medicine & biology.
[28] Douglas L. Miller,et al. DNA transfer and cell killing in epidermoid cells by diagnostic ultrasound activation of contrast agent gas bodies in vitro. , 2003, Ultrasound in medicine & biology.
[29] Paul A Dayton,et al. The magnitude of radiation force on ultrasound contrast agents. , 2002, The Journal of the Acoustical Society of America.
[30] S. Rajagopalan,et al. Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[31] Junru Wu,et al. Reparable sonoporation generated by microstreaming. , 2002, The Journal of the Acoustical Society of America.
[32] A. Klibanov,et al. Detection of individual microbubbles of an ultrasound contrast agent: fundamental and pulse inversion imaging. , 2002, Academic radiology.
[33] E. Unger,et al. Local drug and gene delivery through microbubbles. , 2001, Progress in cardiovascular diseases.
[34] S. Yalkowsky,et al. Solubilization of rapamycin. , 2001, International journal of pharmaceutics.
[35] B D Kahan,et al. Clinical Pharmacokinetics of Sirolimus , 2001, Clinical pharmacokinetics.
[36] P. Dayton,et al. Mechanisms of contrast agent destruction , 2001, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.
[37] M. Manns,et al. Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[38] A Machraoui,et al. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. , 2000, Journal of the American College of Cardiology.
[39] K. Morgan,et al. Optimization of microbubble destruction , 1999, 1999 IEEE Ultrasonics Symposium. Proceedings. International Symposium (Cat. No.99CH37027).
[40] S Marx,et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. , 1999, Circulation.
[41] R. Schwartz,et al. Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodeling. , 1998, The American journal of cardiology.
[42] M. Leon,et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. , 1998, Journal of the American College of Cardiology.
[43] S. Marx,et al. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. , 1995, Circulation research.
[44] William Wijns,et al. A Cause for Concern , 2007 .